Literature DB >> 26647880

Epigallocatechin-3-gallate suppresses alveolar epithelial cell apoptosis in seawater aspiration-induced acute lung injury via inhibiting STAT1-caspase-3/p21 associated pathway.

Wei Liu1, Mingqing Dong2, Liyan Bo1, Congcong Li1, Qingqing Liu1, Zhichao Li2, Faguang Jin1.   

Abstract

The apoptosis of alveolar epithelial cells is important in seawater aspiration‑induced acute lung injury (ALI). The present study aimed to investigate whether epigallocatechin-3-gallate (EGCG) is able to suppress apoptosis in alveolar epithelial cells in seawater aspiration‑induced ALI in vivo and in vitro, and the possible mechanisms underlying it. The results indicated that seawater aspiration‑induced ALI in rats is accompanied by increased apoptosis in lung tissue cells and the expression of apoptosis‑associated proteins, caspase‑3 and p21. EGCG pretreatment significantly ameliorated seawater aspiration‑induced ALI. Furthermore, EGCG decreased seawater aspiration‑induced apoptosis and the expression of caspase‑3 and p21 in lung tissue cells. Seawater‑challenged A549 cells experienced increased apoptosis and elevated levels of phosphorylated‑signal transducer and activator of transcription 1 (P‑STAT1). EGCG pretreatment of the cells resulted in significantly decreased seawater‑induced apoptosis and lower levels of STAT1 and P‑STAT1 in A549 cells. This suggests that EGCG suppresses alveolar epithelial cell apoptosis in seawater aspiration‑induced ALI via inhibiting the STAT1-caspase-3/p21 associated pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26647880     DOI: 10.3892/mmr.2015.4617

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

Review 1.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

2.  Roflumilast, a Phosphodiesterases-4 (PDE4) Inhibitor, Alleviates Sepsis‑induced Acute Kidney Injury.

Authors:  Xingkai Xu; Lulei Liao; Baisheng Hu; Hao Jiang; Meichun Tan
Journal:  Med Sci Monit       Date:  2020-05-25

3.  Mir-331-3p Inhibits PRRSV-2 Replication and Lung Injury by Targeting PRRSV-2 ORF1b and Porcine TNF-α.

Authors:  Xiangbin You; Yilin Qu; Yue Zhang; Jingshu Huang; Xiaoxiao Gao; Chengyu Huang; Gan Luo; Qian Liu; Min Liu; Dequan Xu
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 4.  Phosphodiesterase-4 Inhibitor Roflumilast-Mediated Protective Effect in Sepsis-Induced Late-Phase Event of Acute Kidney Injury: A Narrative Review.

Authors:  Imran Kazmi; Fahad A Al-Abbasi; Muhammad Afzal; Muhammad Shahid Nadeem; Hisham N Altayb; Gaurav Gupta
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-20

Review 5.  Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?

Authors:  Daniela Mokra; Jana Adamcakova; Juraj Mokry
Journal:  Antioxidants (Basel)       Date:  2022-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.